Literature DB >> 24338578

A dose-finding study of preoperative intravenous dexmedetomidine in children's emergence delirium after epiblepharon surgery.

Sohee Yang1, Haemi Lee.   

Abstract

PURPOSE: Emergence delirium (ED) is a leading problem in children after general anesthesia. Dexmedetomidine (DEX) can be administered prior to general anesthesia to decrease ED, although wide ranges of dose are used. This study was conducted to investigate the proper dosages of DEX to attenuate children's ED after sevoflurane anesthesia.
METHODS: Twenty-five children, aged 3 to 9, undergoing repair of epiblepharon were studied. A chosen dosage of DEX was infused for 10 minutes in the preoperative holding area. The dose of DEX started from 0.25 µg/kg, and then was increased or decreased by 0.25 µg/kg depending on the response of the previous patient, using the Dixon up-and-down method. After the surgery under general anesthesia with sevoflurane, ED was assessed by the Cravero 5-point emergence agitation scale (5-point scale) at the postanesthesia care unit. The 50% and 95% effective concentrations (EC50 and EC95 ) of DEX to attenuate ED were calculated by isotonic regression estimators.
RESULTS: The EC50 to attenuate ED was 1.0 (95% confidence interval [CI] 0.29 to 1.71) and EC95 was 1.43 µg/kg (95% CI -1.73 to 4.60). No patient failed parental separation while the Modified Observer's Assessment of Alertness/Sedation Scale at the end of the infusion was scattered from 1 to 5. One child who received 1.50 µg/kg had brief desaturation but recovered soon after being given a verbal command.
CONCLUSIONS: Dexmedetomidine can be safely used between 1.0 and 1.43 µg/kg to attenuate children's ED after sevoflurane anesthesia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24338578     DOI: 10.5301/ejo.5000396

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  2 in total

1.  The effect of the kampo medicine yokukansan on preoperative anxiety and sedation levels.

Authors:  Young-Chang Arai; Jun Kawanishi; Yoshikazu Sakakima; Satoshi Sueoka; Akihiro Ito; Yusuke Tawada; Yuki Maruyama; Shinya Banno; Hitomi Takayama; Makoto Nishihara; Takashi Kawai; Tatsunori Ikemoto
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-31       Impact factor: 2.629

2.  Effect of dexmedetomidine on the Montreal Cognitive Assessment in older patients undergoing pulmonary surgery.

Authors:  Tao Liu; Fang-Chao Liu; Yu Xia; Tai-Jun Luo; Fei Wang; Bin Chen; Chun Wang; Guang-Kuo Gao; Wen-Ting Zhai; Wei Liu
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.